Skip to main navigation Skip to search Skip to main content

COVID-19 Clinical Research: PPD Development: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function...

Project: Research

Project Details

StatusFinished
Effective start/end date07/20/21 → 11/30/23

Funding

  • Gilead Sciences Incorporated: $165,193.00